Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's ...
A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the ...
Scientists used a special imaging technique to observe how Tau protein clumps in the brain tissue of genetically modified ...
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the Tau protein - addressing a critical gap in current treatments.